India TodayBusiness
Cancer drug margins rebound after 2019 price intervention
Margins on cancer drugs have rebounded despite a 2019 intervention aimed at prices, suggesting the policy did not prevent a recovery in profitability. The available report gives no details on which drugs or companies were involved.
This card is an AI-assisted summary of reporting published by India Today. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.